Sensible Medical Innovations Ltd., an Israeli company developing a non-invasive device to monitor patients with congestive heart failure, is opening its first U.S. office in Columbus, Ohio, according to the Columbus Dispatch.
The center invested a total of $1 million in Cardiostar Ltd., Sensible Medical Innovations Ltd. and Vasostar Ltd. Cardiostar is developing a non-invasive way to monitor blood-pressure beat-to-beat, Sensible Medical's device works during congestive heart failure to, among other things, more quickly detect lungs filling with fluid; and Vasostar's catheter would better break up artery blockages known as total chronic occlusion.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.